Biocon's Oral Insulin Fails To Meet Primary Endpoint; Unfazed, Company Says Stage Set For Partnering Talks With Global Pharma

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.